Can stromal-rich tumours rewire colon cancer metabolism to promote therapy resistance?
School of Medicine, Dentistry and Biomedical Sciences
- Location
- Belfast, United Kingdom
- Funding
- See university guidance
- Application deadline
- See university guidance
About the project
My research focuses on how cancer cells rewire their metabolism to survive therapy, progress and interact with the tumour microenvironment. Working across colorectal and lung cancer, my group investigates mechanisms of treatment resistance, including mitochondrial adaptation, nucleotide metabolism, sialylation, KRAS-driven metabolic rewiring and immunometabolic crosstalk. We integrate advanced pre-clinical models, organoids, in vivo systems, multi-omic, imaging and functional analyses to identify therapeutic vulnerabilities and biomarkers that could inform more effective, personalised cancer treatment.
- Dr Emma Kerr: School of Medicine, Dentistry and Biomedical Sciences
Contact info
- View Academic Profile
- Emma.Kerr@qub.ac.uk
- 02890972942
Research Interests
Our lab would suit projects focused on cancer metabolism, therapy resistance, translational oncology and tumour microenvironment biology.
Make a PhD enquiry
Current Research Opportunities
- Can stromal-rich tumours rewire colon cancer metabolism to promote therapy resistance?
Discover More
- Faculty of Medicine, Health and Life Sciences
- School of Medicine, Dentistry and Biomedical Sciences
- Johnston Cancer Research Centre